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Zingiber officinale as an herbal medicinal plant is used for its potential antimicrobial activity against 
different microbial pathogens. Multi-drug resistant Acinetobacter baumannii as an important nosocomial 
pathogen especially in intensive care units is responsible for a wide range of serious infections in humans. 
The purpose of this study was to investigate the antimicrobial activity of Z. officinale extracts on growth of 
A. baumannii strains isolated from hospitalized patients in intensive care units in Tehran, Iran. During a 9 
month study, 50 multi-drug resistant A. baumannii isolates were recovered from patients in ICU. The 
Kirby-Bauer disk diffusion method was used to determine resistance patterns of Multi-drug resistant A. 
baumannii isolates to antimicrobial agents. Micro-broth dilution method was used to determine the 
antimicrobial activity of methanol, acetone, and chloroform extracts of Z. officinale against multi-drug 
resistant A. baumannii isolates. The results of susceptibility testing showed that all the isolates were 
resistant to ceftriaxone, ciprofloxacin, ceftazidime, cefotaxime, cefepime and piperacillin. Resistance to 
colistin was found to be low (4%) and exhibited good antibacterial activity against tested isolates. This 
study’s findings revealed that methanol, acetone, and chloroform extracts of Z. officinale have anti-bacterial 
activity against tested bacterial isolates. Based on the results, the chloroform extracted fraction showed the 
highest level of activity at a minimal inhibitory concentration of 25 mg/ml on multi-drug resistant A. 
baumannii (64%). The minimal inhibitory concentration of ginger extract was as low as 3.2 mg/ml. The 
present study indicated that Z. officinale extracts, at various concentrations could be used as an antibacterial 
agent for treatment of patients in ICUs. 
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INTRODUCTION 
      Acinetobacter baumannii (A. baumannii) as 
an important nosocomial pathogen especially in 
Intensive Care Units (ICUs) is responsible for a 
wide range of infections that can be ranged from 
surgical wounds, urinary tract infections, 
meningitis, and bacteremia to ventilator-
associated pneumonia and other life threatening 
infections [1, 2]. According to the previous 
published data, resistance to antimicrobial agents 
among A. baumannii and emergence of multidrug 
resistant A. baumannii (MDRAB) isolates are 
increasing which could be a serious concern in 
global public health.  A survey in 2008, 
conservatively estimated that in the US, more 
than 12000 people every year are affected by A. 




baumannii infections among which 7300 isolates 
(63%) are confirmed as MDRAB strains with at 
least 500 dying as a result of the infection [3, 4]. 
Antibiotic resistance as a global multifaceted 
phenomenon has become a major threat to global 
health which highlights the need for heightened 
awareness among clinicians, veterinarians, and 
policymakers [5, 6]. In fact, infection with A. 
baumannii clinical isolates are increasingly 
becoming extremely difficult, and sometimes 
impossible to treat which is one of the main 
factors influencing morbidity and mortality 
among patients undergoing these infections [7]. 
With this background, over the past several 
decades, many investigators have paid attention 
to antibacterial activities of natural plants to 
combat antibiotic-resistant bacteria. According to 
data reported by World Health Organization 
(WHO), the use of traditional folk medicine plant 
is common in more than 80% of the world’s 
population [8, 9]. During recent years, extracts, 
essence and oils of herbal plants with 
antibacterial and anti-fungal effects have been 
recruited for treatment of many human infectious 
diseases [10]. In many of the cultures of Asia, 
Africa, and some areas of America, traditional 
medicine has been used for decades to maintain 
human health and also treat various human 
diseases [11]. These herbal plants contain 
ingredients that used for pharmaceutical, food 
and cosmetic industries [12, 13]. Many studies 
have displayed several biological activities of 
herbal medicine including antioxidant, anti-
inflammatory, cell proliferation, immune 
modulating, as well as antibacterial, antiviral, and 
antifungal properties [14-16]. Zingiber officinale 
(Z. officinale), commonly known as ginger, is 
one of these well-known herbal plants that used 
as a popular spice in foods, desserts and drinks all 
around the world. Ginger is a plant with thick 
roots and vertical, upright stems. To date, more 
than 400 active ingredients have been identified 
in ginger. It has been traditionally used for 
treatment of allergy, constipation, asthma, 
diabetes, nervous disorders, gastrointestinal 
disorders, cardiovascular disease and respiratory 
tract infections [17]. Furthermore, various studies 
have confirmed several biological activities of 
ginger including antioxidant, anticoagulation 
activities and anti-inflammatory [18-24]. 
Although antimicrobial activities of ginger has 
been documented, there is scant data about in 
vitro antimicrobial activity of ginger against 
MDR clinical isolates. Considering these points, 
the present study was carried out in order to 
investigate antibacterial activity of methanol, 
acetone and chloroform extracts of ginger against 
MDRAB strains isolated from hospitalized 
patients in intensive care units (ICUs). 
 
MATERIALS AND METHODS 
     The present cross-sectional research was 
conducted from May 2016 to January 2017 on 50 
MDRAB strains recovered from different 
samples of hospitalized patients in ICUs. One 
isolate per patient was included in the study and 
duplicate samples were excluded. Bacterial 
identification was done based on the conventional 
microbiological methods and the API 20 NE 
system (bioMérieux SA, Marcy-1’Etoile, France). 
To ensure identification, A. baumannii isolates 
were subjected to polymerase chain reaction 
(PCR) for detection of blaOXA-51-like gene as 
previously described (Figure 1) [6]. Confirmed A. 
baumannii isolates were stored in Tryptic Soy 
Broth (TSB; Merck, Germany) containing 20% 
glycerol at -70°C for further investigation. 
 
 





Figure 1. PCR of OXA-51 gene products. Lane 1,100 pb DNA ladder;  Lane 2, negative control; Lane 3 positive control; Lane 4 
and 5, OXA-51 gen 
 
Antimicrobial Susceptibility Testing (AST) 
     The susceptibility of MDRAB isolates were 
assessed using the Kirby-Bauer disk diffusion 
technique, according to CLSI guidelines for 
cefotaxime, ceftriaxone, cefepime, ciprofloxacin, 
ceftazidime, piperacillin tazobactam, imipenem, 
meropenem, amikacin, gentamycin, 
trimethoprim/sulfamethoxazole, tetracycline, 
colistin and piperacillin antibiotics. All the 
antibiotic disks used in the present study were 
supplied by Mast Co., UK. Pseudomonas 
aeruginosa strain ATCC 27853 was used as 
quality control strains in each run test.  
Preparation of methanol, acetone, and 
chloroform extracts of ginger  
     Fresh rhizome of the plant was purchased and 
dried in shadow at room temperature of 25 °C. 
The rhizome was ground into fine powder using 
an electrical blender. One hundred grams of the 
powder was mixed in one liter of methanol, 
acetone, and chloroform separately and kept at 
room temperature for 3 days. After three days, 
suspensions were filtered using a Whatman no. 1 
filter paper. The filtered solutions were sterilized 
using a 0.45 micrometer membrane filter. Then, 
the solutions became concentrated and vacuum- 
dried at a low temperature. Dried extract was 
stored at -20°C. 
MIC of ginger 
     To determine the MIC of ginger against 
MDRAB isolates broth, microdilution method 
was carried out in 96-well cell culture plates. In 
brief, the bacterial suspensions, adjusted 
equivalent to a no. 0.5 McFarland standard 
(approximately 1.010
8




 CFU/mL) in the broth media. 
100µl of broth medium was added to each well. 
Fifty mg/ml dilution was considered as stock. 
Serial dilutions of ginger extract (25, 12.5, 6.25, 
3.125, 1.56, 0.78, 0.39 and 0.19 mg/ml) were 
prepared as follow; 100 µl of the extract (50 
mg/ml) was added to the first well to achieve 1/2 
dilution. Next,   100 µl of the first well was 
transferred to the second well to achieve 1/4 
dilution and concentrations of the extract were 
prepared and dispensed in 96-well cell culture 
plates. Twenty microliters of each bacterial 
suspension was added to each well and incubated 
at 37˚C overnight. Positive and negative controls 
were used in each run test [6]. To estimate MIC 
of ginger, the absorbance of each well was 
measured at 595 nm.  
Data analysis  
     Statistical analysis was performed using SPSS 




     The average age of the patients was 41 years 
(range, 1 to 86 years). A. baumannii infection 
was highest in the 46-60 year age group (40%) 
and lowest in the 1 to 15 years age group (2%). 
From 50 isolates included in the study, 35 isolates 
(70%) were recovered from male patients and 15 
isolates (30%) from female patients. According to 
the AST results, all isolates were resistance to 
ceftriaxone, ciprofloxacin, ceftazidime, 
cefotaxime, cefepime and piperacillin. The 
highest level of resistance among tested isolates 
was observed to be related to piperacilin 




tazobactam (98%), followed by imipenem (96%), 
meropenem (96%), 
trimethoprim/sulfamethoxazole (88%), 
gentamycin (86%), amikacin (80%) and 
tetracycline (64%).  
Antibacterial activity of ginger extracts 
The findings obtained of antibacterial activity 
assessment of ginger revealed that at MIC 25 and 
12.5 mg/ml, chloroform extract, at MIC 6.25 
mg/ml both methanol and acetone extract and at 
MIC 3.125 mg/ml acetone and chloroform extract 
had the most antibacterial activity against 
MDRAB isolates. These differences were not 
significant (P>0.05). None of the MDRAB 
isolates were sensitive to dilutions of ginger equal 
and less than 0.78 mg/ml. In vitro susceptibility 
of different concentration of extracts against the 
MDRAB isolates are summarized in Table 1. 
 
Table 1. Summary of the antibacterial activities of methanol, acetone and chloroform extracts of ginger against MDRAB isolates. 
Ginger extract MIC (mg/ml) N (%) 
25 12.5 6.25 3.125 1.56 0.78 0.39 0.19 
Methanol MIC 30 (60) 11 (22) 6 (12) 3 (6) 0 (0) 0 (0) 0 (0) 0 (0) 
MBC 41 (82) 6 (12) 3 (6) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
Acetone 
 
MIC 22 (44) 13 (26) 6 (12) 4 (8) 5 (10) 0 (0) 0 (0) 0 (0) 
MBC 22 (44) 13 (26) 6 (12) 4 (8) 5 (10) 0 (0) 0 (0) 0 (0) 
Chloroform MIC 32 (64) 15 (30) 5 (10) 4 (8) 4 (8) 0 (0) 0 (0) 0 (0) 
MBC 32 (64) 15 (30) 5 (10) 4 (8) 4 (8) 0 (0) 0 (0) 0 (0) 
 
DISCUSSION  
     Although antimicrobial properties of ginger 
are primarily recognized, there have been no 
published data on MDRAB isolates in Iran. The 
results of the present study showed that 98% of 
MDRAB strains isolated from hospitalized 
patients in ICU were resistant to at least three 
antibiotics. The evaluation of pattern of antibiotic 
resistance of MDRAB isolates also showed that 
the highest resistance rate was reported to be 
against ceftriaxone, ceftazidime, cefotaxime, 
cefepime and ciprofloxacin while the lowest rate 
of resistance was reported for colistin, 
tetracycline and amikacin.  
In line with the present study’s results, Arunava 
et al. (2013) reported highest resistance rate 
against gentamycin (100%), ceftazidime (81.1%), 
amikacin and ciprofloxacin (72.7%). They 
showed that 22.4% of tested isolates were 
resistant to imipenem and colistin and polimixin 
B had good activity against A. baumannii strains. 
The comparison of the rate of resistance in both 
studies shows that colistin is considered as the 
best antibiotic for treatment of A. baumannii 
infections. However, difference in antibiotic 
resistance patterns in various studies could be 
related to factors such as geographical area under 
study, type of samples, duration of study and also 
the special therapeutic protocols. In another study 
form Iran, the rate of resistance to tazobactam, 
ticarcillin, amikacin and imipenem were 88.2%, 
84.7%, 81.7% and 52.9% respectively [25]. In 
this study, polymixin B (90%) and colistin 
(65.9%) had the best antibacterial activities 
against A. baumannii strains. 
In another study conducted in Iran by Meradji et 
al. in which 80 A. baumannii strains were 
investigated, the highest resistance rate was 
reported for ticarcillin (61.25%), followed by 
ceftazidime and ticarcillin/clavulanic acid 
(56.25%). Likewise, colistin and amikacin were 
determined as the most effective antibiotics in 
this study with 93.90% and 100% sensitivity 
respectively [26]. There are discrepancies in the 
antimicrobial effects of various extracts of ginger. 
In the present study, the majority of strains were 
inhibited by methanol, chloroform and acetone 
extract of ginger at MIC 25 mg/ml. The results of 
observations exhibited good activity of ginger 
extracts against MDRAB isolates. However, the 
acetone extract of ginger showed that its 
antibacterial activity initiated in lower 
concentration than other extracts, but there is no 
significant statistical difference. Ranjit Thakur 
(2013) evaluated the antibacterial effect of 
ethanol extract of ginger, cinnamon and turmeric 
on Escherichia coli and P. aeruginosa and 
Klebsiella pneumonia strains by disk diffusion 
method. The results of their study showed that 
ethanol extract of turmeric inhibited the growth 
of all the bacteria while ethanol extract of 
cinnamon did not show any effect on these 




bacteria. Ethanol extract of ginger had a high 
inhibitory effect on growth of E. coli and showed 
a moderate effect on P. aeruginosa and klebsiella 
[15]. In a study conducted by Usha et al. (2012) 
in India, the antibacterial effects of ethanol and 
acetone extract of cinnamon on strains of P. 
aeruginosa were evaluated by disk diffusion and 
MIC methods. The MIC of ethanol and acetone 
extract of cinnamon on P. aeruginosa was 32 
mg/ml and 16.64 mg/ml respectively [27]. Gull et 
al (2012) evaluated the antibacterial effects of 
aqueous, methanol and ethanol extracts of garlic 
and ginger on P. aeruginosa by disk diffusion and 
MIC methods. They found that aqueous extract of 
garlic had  excellent  antibacterial 
activity against all the test strains while aqueous 
extract of ginger did not show any antibacterial 
activity. They also showed that strains were 
inhibited by aqueous extract of garlic at MIC 0.2-
0.5 mg/ml, ethanol extract at MIC 0.05-0.5 
mg/ml and methanol extract at MIC 0.09-0.7 
mg/ml [28]. In another study conducted in India, 
antibacterial effect of garlic and ginger extracts 
were assessed against MDR P. aeruginosa. This 
study exhibited that ethanol extract of garlic has 
higher and broader spectrum of antimicrobial 
activity than ginger on P. aeruginosa [29]. In 
Adeshina’s study who considered the 
antibacterial activity of aqueous extract of red 
and white onion on Escherichia coli, P. 
aeruginosa, Salmonella typhi and Staphylococcus 
aureus, all the tested isolates were resistant to 
aqueous extract of ginger and aqueous extract of 
red and white onion had a strong activity at MIC 
3.125-25 with the exception of S. aureus [30]. 
The study of Aghazadeh et al in 2016 was done in 
order to evaluate the antibacterial activity of 
ethanol extract of ginger and its effect on biofilm 
formation. In this experimental study, the ethanol 
extract of ginger was evaluated as a mouthwash 
against fungi and bacteria. Their findings showed 
that P. aeruginosa, S. aureus, K. pneumonia, 
Bacillus cereus, A. baumannii, Candida albicans 
and Candida cruzei strains were inhibited by 
ethanol extract ginger at MIC 10, 20, 20, 20, 20, 
40 and 40 mg/ml, respectively [31]. There are 
differences in the antimicrobial effects of various 
extracts of ginger. Wang et al (2010) showed that 
6-hydro gingerol, 10-gingerol, 6- shogaol, and 6-
gingerol are 4 main compounds present in ginger 
which have a strong antibacterial effect against 
extensively drug-resistant A. baumannii. It is well 
established that the concentration of this 
compounds in ginger is directly related to its 
antibacterial effect. Therefore, different organic 
solvents and applied techniques in preparation of 




     In conclusion, the present study showed that 
ginger extract could be active against MDRAB 
strains at various concentrations and the use of it 
at optimum concentrations can help better therapy 
of many microbial diseases. However, further 
studies in order to identify bioactive components 
ginger are necessary and also help to use the 
ginger as an alternative option for treatment of 
many microbial diseases.  
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